Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of GPC-3 CAR-T Cells in Advanced Hepatocellular Carcinoma

NCT05620706 is registered in ClinicalTrials.gov with Shenzhen University General Hospital as lead sponsor.

NCT NCT05620706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05620706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of GPC-3 CAR-T Cells in Advanced Hepatocellular Carcinoma
Lead sponsor
Shenzhen University General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2022
Completion date
October 31, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced hepatocellular carcinoma